Abnova was founded in 2002 in Taipei, Taiwan and is currently the world's largest supplier of antibodies.
The human genomic project has identified most human expressed genes and the full-length cDNAs of these genes are available to the public. Abnova aims to produce at least one antibody for every human expressed gene in the human genome. The company develops their products using new genomic and proteomic tools and applications.
Abnova products are manufactured in house in their state-of-art production and SPF animal facilities in Jhongli, Taiwan. Their large scale production is supported by optimal infrastructure which allows maximum productivity. Abnova also offers multiple clones for the monoclonal antibody, and their access is available to partners and collaborators in academia and industry.